In a nutshell This study aimed to find out if radiation added to standard chemotherapy could increase the response to treatment for locally advanced breast cancer. This study found that neoadjuvant radiation added to chemotherapy improved response but not overall survival. Some background Chemotherapy is a treatment option for...
Read More
In a nutshell This study examined rates of biochemical relapse after using intraoperatively planned low-dose-rate prostate brachytherapy using an automated delivery system (IO-LDRB) in men with low and intermediate stage prostate cancer. This study found that rates of biochemical relapse were low after treatment. Some background...
Read More
In a nutshell This study aimed to identify risk factors of recurrence after prostatectomy in high risk patients. Patients with more risk factors were more likely to experience disease recurrence at five years. Some background Prostatectomy is a treatment option for prostate cancer. The prostate tumor is surgically removed. There are several risk...
Read MoreIn a nutshell This study examined whether patients had a higher risk of thromboembolism depending on the chemotherapy drug they received. The study concluded that patients treated with carboplatin had no difference in the risk of thromboembolism compared to patients treating with cisplatin. Some background Chemotherapy is one of the most well-known...
Read More
In a nutshell This study examined whether loratadine (Claritin) or naproxen (Aleve) is better at treating bone pain associated with G-CSF treatment for patients undergoing chemotherapy for early stage breast cancer. This study concluded that there was no significant difference between the incidence of bone pain reported by patients...
Read More
In a nutshell The authors reviewed data from recent clinical trials to update guidelines on treating early stage inoperable non-small-cell lung cancer (NSCLC). This article provided a summarized account of the updates included in the American Society for Radiation Oncology guidelines for treating NSCLC. Some background For patients with early...
Read MoreIn a nutshell This trial is examining the effectiveness of a probiotic (Primal Defense Ultra (R) Probiotic Formula) for the immune systems of patients with breast cancer. The main outcome to be measured is the number of cytotoxic T lymphocytes (CD8+), a type of white blood cell. This study is being conducted in the Mayo Clinic in...
Read More
In a nutshell This trial is examining the effectiveness of nature sounds to reduce pain and anxiety in patients undergoing breast core biopsy. The main outcome to be measured will be anxiety and pain scores. The study is being conducted in Chicago, Illinois, in the United States. The details A biopsy can be a stressful test for patients...
Read More
In a nutshell This trial is examining the effectiveness of nivolumab (Opdivo) in combination with cabozantinib (Cometriq) for metastatic triple-negative breast cancer (cancer that is not dependent on hormones or HER2 for growth). The outcome to be measured will be the response rate of the cancer to this treatment. This study is...
Read More
In a nutshell This trial is examining the effectiveness of the antibody-drug conjugate SYD985 for HER2-positive inoperable advanced breast cancer. The main outcome to be measured will be time from treatment until disease progression or the time taken for tumor growth or spread. This study is being conducted in Baltimore, Maryland, inthe United...
Read MoreIn a nutshell This study looked at the effectiveness of the chemotherapy drug nedaplatin (Aqupla) to treat specific types of non-small-cell lung cancer (NSCLC). The authors concluded that nedaplatin was effective at treating patients with squamous cell lung cancer. Some background Targeted therapy has improved the outcome of certain types of NSCLC...
Read More
In a nutshell This study looked at different combinations of local and systemic therapy for treating patients with advanced non-small-cell lung cancer (NSCLC). The authors concluded that this type of aggressive combination therapy could improve survival rates of these patients. Some background Roughly half of patients with NSCLC are not diagnosed...
Read More
